Apivax™ is the trademarked named of our anti-fungal vaccine for honey bees that is in our research pipeline. It’s name is derived from “Apis”, the genus within which honey bees are phylogentically categorized, and “vaccine”. This research is funded entirely from funds raised from the sales and management of Best Bees™ honey bee hives, in addition to our ongoing fundraising efforts. Stay tuned for more updates about Apivax™ and all of our other research projects!
Check out Dr. Noah Wilson-Rich’s 60-second elevator pitch about Apivax™ at the link below. Noah’s pitch ranked second place overall out of 306 companies at the 2010 MIT 100K Entrepreneurship Competition, and first for the life sciences.
(jump to minute 34!)